These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 10023683)
1. Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells. Hurd C; Dinda S; Khattree N; Moudgil VK Oncogene; 1999 Jan; 18(4):1067-72. PubMed ID: 10023683 [TBL] [Abstract][Full Text] [Related]
2. Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells. Hurd C; Khattree N; Dinda S; Alban P; Moudgil VK Oncogene; 1997 Aug; 15(8):991-5. PubMed ID: 9285694 [TBL] [Abstract][Full Text] [Related]
3. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
4. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships. Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830 [TBL] [Abstract][Full Text] [Related]
5. Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation. Duan R; Porter W; Safe S Endocrinology; 1998 Apr; 139(4):1981-90. PubMed ID: 9528985 [TBL] [Abstract][Full Text] [Related]
6. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Jeng MH; Parker CJ; Jordan VC Cancer Res; 1992 Dec; 52(23):6539-46. PubMed ID: 1423300 [TBL] [Abstract][Full Text] [Related]
7. Regulation of pS2 gene expression by affinity labeling and reversibly binding estrogens and antiestrogens: comparison of effects on the native gene and on pS2-chloramphenicol acetyltransferase fusion genes transfected into MCF-7 human breast cancer cells. Weaver CA; Springer PA; Katzenellenbogen BS Mol Endocrinol; 1988 Oct; 2(10):936-45. PubMed ID: 2460749 [TBL] [Abstract][Full Text] [Related]
8. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha. Kinoshita Y; Chen S Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940 [TBL] [Abstract][Full Text] [Related]
9. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Sengupta K; Banerjee S; Saxena N; Banerjee SK Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749 [TBL] [Abstract][Full Text] [Related]
11. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
12. Hormonal regulation of tumor suppressor proteins in breast cancer cells. Moudgil VK; Dinda S; Khattree N; Jhanwar S; Alban P; Hurd C J Steroid Biochem Mol Biol; 2001; 76(1-5):105-17. PubMed ID: 11384868 [TBL] [Abstract][Full Text] [Related]
13. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: role of estrogen receptor-Sp1 interactions. Xie W; Duan R; Safe S Endocrinology; 1999 Jan; 140(1):219-27. PubMed ID: 9886828 [TBL] [Abstract][Full Text] [Related]
14. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Marsaud V; Gougelet A; Maillard S; Renoir JM Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746 [TBL] [Abstract][Full Text] [Related]
15. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines. Müller V; Jensen EV; Knabbe C Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403 [TBL] [Abstract][Full Text] [Related]
16. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells: antiestrogen selectivity and promoter dependence. Fujimoto N; Katzenellenbogen BS Mol Endocrinol; 1994 Mar; 8(3):296-304. PubMed ID: 7517003 [TBL] [Abstract][Full Text] [Related]
17. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators. Cho H; Katzenellenbogen BS Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375 [TBL] [Abstract][Full Text] [Related]
18. Estradiol induction of retinoic acid receptors in human breast cancer cells. Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407 [TBL] [Abstract][Full Text] [Related]
19. Role of estrogen receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene expression. Porter W; Wang F; Wang W; Duan R; Safe S Mol Endocrinol; 1996 Nov; 10(11):1371-8. PubMed ID: 8923463 [TBL] [Abstract][Full Text] [Related]
20. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]